[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Revolving door spins", "description": "Pandemic deputy chief medical officer moves to Moderna\n\nSir Jonathan Van-Tam\nhttps://www.msn.com/en-gb/health/other/covid-guru-jonathan-van-tam-lands-senior-role-at-vaccine-maker-moderna/ar-AA1frazv\n\nhttps://www.theguardian.com/business/2023/aug/18/former-covid-medical-officer-van-tam-takes-role-at-vaccine-maker-moderna\n\nhttps://www.linkedin.com/posts/modernatx_moderna-is-delighted-to-announce-that-professor-activity-7059151698870579200-jF22/\n\nUK former deputy chief medical officer\n\nSenior Strategy Adviser in Medicine (Nottingham University)\n\nNow (as of 2nd May) a senior medical consultant to the Covid-19 vaccine maker Moderna.\n\nWas a member of the government vaccine taskforce during pandemic,\n\nMade decisions on 'all vaccine supply contracts and major investments in manufacturing and clinical opportunities'.\n\nhttps://www.youtube.com/watch?v=NJM9k1kq6ko\n\nhttps://www.youtube.com/watch?v=kb7oMMYx0Yc\n\nUK government \n\nBritain bought 77,000,000 moderna vaccines\n\nStruck a 10-year \u00a3billion partnership with Modern to build a new factory\n\nhttps://www.theguardian.com/business/2022/jun/22/moderna-build-uk-mrna-vaccine-research-manufacturing-centre-covid\n\nGovernment has committed to buying Moderna\u2019s vaccines for the next decade.\n\nJVT \u2018advisory fee\u2019, not disclosed\n\nProhibited from using privileged information from his time in government to further his business interests\n\nRose Whiffen, Transparency International UK\n\n'Currently, there are only threadbare safeguards against abuse of the revolving door between the public and private sector.'\n\nCreated a 'risk of privileged information being misused for commercial benefit'.\nhttps://www.gov.uk/government/people/patrick-vallance\n\nGovernment Chief Scientific Adviser, April 2018 to April 2023\n\nPresident, R&amp;D at GlaxoSmithKline, 2012 to 2017\n\nHad been Senior Vice President, Medicines Discovery and Development\n\n(joined the company in May 2006 as Head of Drug Discovery)\n\nHe was a member of the GSK Board and the Corporate Executive Team. \n\nhttps://www.theguardian.com/uk-news/2021/mar/19/patrick-vallance-adviser-scientific-truth-to-power\n\nhttps://www.gsk.com/media/5346/remuneration-report.pdf\n\nTotal of pay and bonuses in 2017, \u00a3 4,400,000\n\nSold most of his GSK bonus shares before joining the government\n\n(except \u00a3600,000)\n\nChief science adviser pay was \u00a3185,000.\n\nIs the US squeaky clean?\n\nhttps://www.science.org/content/article/fda-s-revolving-door-companies-often-hire-agency-staffers-who-managed-their-successful\n\nhttps://www.npr.org/sections/health-shots/2016/09/28/495694559/a-look-at-how-the-revolving-door-spins-from-fda-to-industry", "link": "https://www.youtube.com/watch?v=nn-VBo-edHY", "date_published": "2023-08-19T08:40:50+00:00", "persistent": false, "dead": false, "artist": null, "album": null, "user": null, "language": "en-UK", "thumbnail": "https://i3.ytimg.com/vi/nn-VBo-edHY/hqdefault.jpg"}]